Your search returned 36 results.

Sort
Results
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†. [electronic resource] by
Producer: 20150707 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.